Metastatic Colorectal Cancers Active Not Recruiting Phase 2 Trials for Regorafenib (DB08896)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01298570Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal CancerTreatment
NCT02466009Regorafenib in Metastatic Colorectal CancerTreatment
NCT02835924Study Comparing Different Dose Approaches of Induction Treatment of Regorafenib in MCRCTreatment
NCT01949194Study to Determine the Efficacy of Regorafenib in Metastatic Colorectal Cancer Patients and to Discover BiomarkersTreatment